PipelinePharma Logo

Generics Products found!

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Cilostazol manufacturers

Filters

Filters

Filters , active

Country of origin : India

Clear all

None products found

cilostazol

Tablets 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
India
Manufacturer #18530

This pharmaceutical company specializes in a diverse range of products including prescription medications, over-the-counter drugs, medical devices, and supplements. They hold WHO-GMP certifications since 1965 and an ISO 9001:2015 certification, demonstrating their commitment to quality. Their expertise spans various therapy areas such as oncology/hormone therapies, cardiovascular health, and gastrointestinal conditions. They offer a wide range of dosage forms including capsules, tablets, syrups, and rectal suspensions. This company has a global presence, with products distributed across over 2000 countries. They are known for their contract manufacturing capabilities and new drug development expertise, holding over 300 ACTD dossiers.

Manufacturer usually replies in 13 days

cilostazol

Tablets 50 mg, 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #3825

Established in 1994, this GMP manufacturer specializes in the development and production of CTD dossiers. As a CTD dossier owner and manufacturer, it ensures quality compliance across various markets. With GMP approvals, it showcases commitment to high standards. The manufacturer operates multiple production lines designed for diverse pharmaceutical formulations, catering to a wide range of needs. Its products are sold in over 25 countries and regions worldwide, supported by a dedicated team of around 300 employees. This GMP manufacturer excels as a CTD dossier owner and manufacturer, meeting global regulatory requirements efficiently.

Manufacturer usually replies in 45 days

cilostazol

Tablets 50 mg, 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17691
This company is a global pharmaceutical manufacturer with a focus on developing and manufacturing a wide range of high-quality injectable medicines. They provide a diverse product portfolio encompassing tablets, capsules, injectables, dry syrups, liquids, drops, creams, and inhalers. The company operates in the European Union and North America, demonstrating compliance with international quality standards. Their dedication to innovation and customer satisfaction is reflected in their in-house design department and their commitment to providing cost-effective solutions and reliable supply chains. Key therapy areas include cardiology, oncology, and infectious diseases, though other areas are also likely addressed. The company has a history of providing custom manufacturing solutions and research and development services, highlighting their expertise in the industry.

Manufacturer usually replies in 32 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Cilostazol is a medication used to treat intermittent claudication in peripheral vascular disease. Suppliers of cilostazol market it in the form of 50mg and 100mg tablets. The drug was first introduced into the pharmaceutical market in 1999 and has since then become a widely prescribed medication with over a million prescriptions of cilostazol registered yearly in the U.S. alone. The largest manufacturers of cilostazol globally include GlaxoSmithKline, Bristol-Myers Squibb, Bedford Laboratories, Takeda, Novartis, Mylan, Abbot, and Pfizer. Cilostazol suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified cilostazol manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform. The retail prices per 56 (100mg) tablets of cilostazol fall into an approximate range of 15,00 EUR to 20,00 EUR.

Popular Searches

Amoxicillin manufacturers Atorvastatin manufacturers Benzocaine manufacturers Calcium carbonate manufacturers Cloperastine fendizoate manufacturers Gabapentin manufacturers Hyaluronic acid manufacturers Ibuprofen manufacturers Ivermectin manufacturers Levothyroxine manufacturers Lisinopril manufacturers Losartan manufacturers Magnesium manufacturers Melatonin manufacturers Metformin manufacturers Methotrexate manufacturers Metoprolol manufacturers Omeprazole manufacturers Paracetamol manufacturers Prednisone manufacturers Pregabalin manufacturers Semaglutide manufacturers Testosterone enanthate manufacturers Vitamin B12 manufacturers

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.